SecBot SecBot

INIS

RADNOSTIX INC
OTC· Industrial Instruments For Measurement, Display, and Control· Inc. TX· CIK 0001038277 Industrials & Manufacturing
$0.0380 −0.01 (−24.00%)
Oct 27 4:00 PM ET · prev $0.0500
Next earnings
Nov 12
in 16 days
1 year
−36.7%
from $0.0600 · Oct 28
30 days
−36.7%
from $0.0600
52-week range
$0.0380–0.1100
at the low
Avg volume 20D
71.2K
Oct 19 spike 264.3K
Short interest
13.9K
+734.9%
Days to cover
1.0
at average volume
Insider net
+$250.0B
1 buyer · 0 sellers · 12 mo
Filing reports
5
analyzed by SecBot
SecBot read BULLISH 1 report · 90 days
Balance 0 bearish · 1 bullish oldest → newest, height = score
Avg score ·Next Earnings date, Nov 12, 2026
Strongest BULLISH Radnostix (INIS) signed a definitive asset purchase agreement to sell its DUF6 deconversion and fluorine…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $250.0B. No open-market sales.

  • Short sellersBUILDING

    Short interest +734.9% to 13.9K shares. 1.0 days to cover.

  • TrendDOWNTREND

    33% below its 50-day average. New closing low $0.0380 on Oct 27.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
INIS Q3 2026 Earnings Scheduled — 2026-11-12
Recent
Aug 11, 2026
Earnings date
INIS Q2 2026 Earnings Scheduled — 2026-08-11
May 19, 2026
Earnings date
INIS Q1 2026 Earnings Scheduled — 2026-05-19
Apr 6, 2026
Earnings date
INIS Q4 2025 Earnings Scheduled — 2026-04-06
Mar 11, 2026
FDA
Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.
Class II: Presence of Particulate Matter: Due to production issues
Mar 11, 2026
FDA
Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.
Class II: Presence of Particulate Matter: Due to production issues

Insider ledger

Form 4
$250.0B
bought · 1 insider
$0
sold · 0 insiders
DateInsiderTypeValue
Jun 26, 2026
GROSSO CHRISTOPHER G
Director
BUY$250.0B
Feb 17, 2025
GROSSO CHRISTOPHER G
Director
OTHER269,999 sh
Feb 17, 2025
GROSSO CHRISTOPHER G
Director
OTHER40,384 sh
Feb 17, 2025
GROSSO CHRISTOPHER G
Director
OTHER230,769 sh

Earnings setup

Estimates
Nov 12
reports in 16 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
13,885
shares short
+734.9%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 SEC
Radnostix (INIS) signed a definitive asset purchase agreement to sell its DUF6 deconversion and fluorine extraction…
8-K — Impact 6/10
Aug 11, 2026 Earnings calendar
INIS Q2 2026 Earnings Scheduled — 2026-08-11
Jul 21, 2026 SEC
Radnostix Inc held its 2026 Annual Meeting on July 16, 2026, with shareholders approving the 2026 Incentive Plan…
8-K — Impact 2/10
Jun 26, 2026 Insider
GROSSO CHRISTOPHER G bought 500,000 shares
Director @ $500,000.00 ($250.0B)
Jun 4, 2026 SEC
Radnostix Inc. filed a DEFA14A (definitive additional proxy soliciting materials) on June 4, 2026. The filing contains…
DEFA14A — Impact 2/10
Mar 11, 2026 Event
Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.
Class II: Presence of Particulate Matter: Due to production issues
Feb 17, 2025 Insider
GROSSO CHRISTOPHER G acquired 269,999 shares
Director
Feb 17, 2025 Insider
GROSSO CHRISTOPHER G acquired 40,384 shares
Director

SecBot reports

5 filings · 1 bullish · 0 bearish · 4 neutral
All INIS filing & press-release reports (5)